Muscle wasting in hemodialysis and lung cancer patients is mediated through down and up-regulation of several proteins common to both diseases

Archive ouverte

Aniort, Julien | Polge, Cécile | Claustre, Agnes | Combaret, Lydie | Béchet, Daniel | Attaix, Didier | Heng, Anne-Elisabeth | Taillandier, Daniel

Edité par CCSD -

Session Proteasomes, Structure & Function Organizing Committee: Chairs: Didier Attaix, Lydie Combaret and Daniel Taillandier
Session Proteasomes, Structure & FunctionOrganizing Committee: Chairs: Didier Attaix, Lydie Combaret and Daniel Taillandier. Introduction: Muscle atrophy is frequently encountered in diseased patients. It contributes to patient’s frailty and is associated with an increased risk of death. Studies using animal models suggest the involvement of the Ubiquitin Proteasome System (UPS) in renal failure-induced muscle atrophy. However, this remains to be established in humans. Another important goal is to detect markers that may help fighting against muscle atrophy through nutritional or pharmacological strategies. Indeed, it is very difficult to counteract the increased proteolysis when it is established. Our objectives were (i) to identify the proteolytic systems activated in chronic hemodialysis (HD) or lung cancer (LC) patients, i.e. pathologies having a different etiology and (ii) to identify markers specific to the activation of muscle atrophy processes independently of the pathology per se.Methods: Muscle biopsies (n = 7 per group) were obtained upon programmed surgery. mRNA and protein levels were determined using qRT-PCR, immunoblotting and proteomic approaches. Results: We found that the UPS and autophagy were activated in both HD and LC patients. Mass spectrometry analysis identified > 1700 proteins. Main component analysis revealed 3 distinct protein expression profiles corresponding to the 3 groups studied. We identified 106 proteins that were significantly modified (decreased or increased) in both HD and LC patients compared to controls (CT). Hierarchical cluster analysis showed that expression levels of these proteins distinguished diseased (HD or LC) vs. CT patients. Orthogonal partial least square discriminant analysis confirmed these results.Conclusion: We demonstrated that the UPS and autophagy were activated during long-term disease in humans. We also found a set of proteins whose expression levels may be specific of the atrophying process. These proteins constitute potential biomarkers witnessing the activation of muscle atrophy and/or potential therapeutic targets.

Consulter en ligne

Suggestions

Du même auteur

Muscle wasting in patients with end-stage renal disease or early-stage lung cancer: Common mechanisms at work

Archive ouverte | Aniort, Julien | CCSD

Loss of muscle mass aggravates many diseases such as cancer and renal failure, contributes to the frailty syndrome and is associated with an increased risk of death (1, 2). Studies conducted on animal models have revealed the prep...

Muscle wasting in patients with end‐stage renal disease or early‐stage lung cancer: common mechanisms at work

Archive ouverte | Aniort, Julien | CCSD

International audience. Background Loss of muscle mass worsens many diseases such as cancer and renal failure, contributes to the frailty syndrome , and is associated with an increased risk of death. Studies conduct...

UBE2E1 Is Preferentially Expressed in the Cytoplasm of Slow-Twitch Fibers and Protects Skeletal Muscles from Exacerbated Atrophy upon Dexamethasone Treatment

Archive ouverte | Polge, Cécile | CCSD

Correction: Volume: 7 Issue: 12 Article Number: 242 DOI: 10.3390/cells7120242 PMID: 30518141. UBE2E1 Is Preferentially Expressed in the Cytoplasm of Slow-Twitch Fibers and Protects Skeletal Muscles from Exacerbated ...

Chargement des enrichissements...